Bellevue Group »

Gmr Solutions shares owned by Bellevue Group

Quarter-by-quarter ownership of Gmr Solutions shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Gmr Solutions

Tip: Access up to 7 years of quarterly data

All positions including Gmr Solutions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gmr Solutions by Bellevue Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.2M 333k 15.46

More positions owned by Bellevue Group

Amgen (AMGN)
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Gilead Sciences (GILD)
Revolution Medicines (RVMD)
Oruka Therapeutics (ORKA)
Insmed Com Par $.01 (INSM)
Scholar Rock Hldg Corp (SRRK)
Nuvalent Inc-a (NUVL)
Miragen Therapeutics (VRDN)
Relay Therapeutics (RLAY)
Vaxcyte (PCVX)
United Therapeutics Corporation (UTHR)
Intuitive Surgical Com New (ISRG)
Regeneron Pharmaceuticals (REGN)

View all positions for Bellevue Group

Top funds holding Gmr Solutions

Kohlberg Kravis Roberts & Co
FMR
Citadel Advisors
Invesco
Norges Bank Investment Management
Healthcare Of Ontario Pension Plan Trust Fund
Alyeska Investment Group
Koch
Alberta Investment Management Corporation
Ensign Peak Advisors
BlackRock
Holocene Advisors
Woodline Partners
Unisphere Establishment
Readystate Asset Management

View all funds holding Gmr Solutions